Patients completed surveys to evaluate symptoms including depression, anxiety, and functional status. The National Comprehensive Cancer Network (NCCN) Distress Thermometer and Problem List and Functional Activity Scale (FAS) [11 (link)–14 (link)] surveys were collected at each visit (every 3-to-4 weeks). Patients were also asked to complete the following surveys every 3 months for up to 1 year: European Organization for Research and Treatment of Cancer (EORTC), Quality of Life of Cancer Patients (QLC-C30), Quality of Life-Lung Cancer 13 (QLQ-LC-13) [15 (link), 16 (link)], and the Hospital Anxiety and Depression Scale (HADS) [17 (link)]. For EORTC, the scores range from 0 to 100 with higher scores indicating a healthy level of functioning and lower scores indicating a high level of symptomatology. The HADS is a 14-item scale with seven items each for anxiety and depression subscales. Scoring for each item ranges from 0 to 3. A subscale score ≥ 8 denotes anxiety or depression [18 (link)]. At baseline only, patients completed the Screener and Opioid Assessment for Patients with Pain-Revised (SOAPP-R) to assess opioid abuse risk [10 (link), 19 (link)]. Patient acceptability questions regarding patient opinions within the Onco-Pall model were completed once at the 3-month time point. This consisted of five questions to assess patient preferences regarding palliative care appointments, including timing, location, length of visit, and open-ended feedback. The caregivers were asked to complete the Supportive Care Needs Survey–Patients & Caregivers (SCNC-P&C) at baseline and then every 3 months for up to 1 year [20 (link), 21 (link)].
Free full text: Click here